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ABSTRACT
Irisin is a novel exercise-induced myokine that may be involved in regulating energy metabolism. We
determined whether overtraining syndrome (OTS) and its biochemical markers are associated with plasma
irisin levels in athletes. Seven severely overtrained athletes (OA) and 10 healthy control athletes (CA) were
recruited and examined at the time of diagnosis (baseline) and after 6- and 12-months follow-up. Training
volume and intensity were initially restricted but progressively increased in OA as OTS symptoms alle-
viated; CA continued their normal training routine. A maximal cycle ergometer test was performed with
irisin analyzed before and after the test. Before the exercise test, irisin levels tended to be lower in OA than
in CA at baseline (154.5 ± 28.5 vs. 171.7 ± 58.7 ng/mL). In both groups, at rest irisin levels changed only
marginally during follow-up and were not affected by maximal exercise, nor were they associated with
physical performance or body fat percentage. Irisin concentration at rest correlated positively with an
oxidative stress marker, malondialdehyde (MDA) and negatively with an antioxidant protection marker,
oxygen radical absorbance capacity (ORAC) in response to the exercise test in OA at baseline. Our findings
pCorresponding author. E-mail: mustafa.atalay@uef.fi
yThese two authors contributed equally to this work.
Physiology International 107 (2020) 4, 513–526
DOI: 10.1556/2060.2020.00037
help to clarify the possible contribution of irisin and its association with oxidative stress in the patho-
physiology of OTS.
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INTRODUCTION
Overtraining syndrome (OTS) in athletes is a chronic physical stress condition that remains a
diagnostic challenge due to the lack of reliable parameters for the evaluation of OTS or for
monitoring recovery from OTS [1]. Although multiple mechanisms have been proposed, the
pathophysiology of OTS and the associated long-term performance impairment is not entirely
clear [2–6]. Putative pathophysiological mechanisms include impairments in skeletal muscle
carbohydrate and lipid metabolism [4], increased oxidative stress [6, 7], muscle microtrauma-
induced chronic inflammation [5], and inappropriate production and activities of cytokines such
as interleukin-6 (IL-6) [8], as well as hormonal alterations [9–12]. Notably, the interaction
between different mechanisms related to the pathogenesis of OTS have not been elucidated.
Some novel clinical and biochemical markers of OTS have recently been explored, and new
pathophysiological mechanisms have been proposed, although they need further confirmation.
OTS is inherently severe and therefore, the main difference between OTS and overreaching
states is a lack of recovery after a period of resting, and the duration and severity of the
symptoms. While OTS has been postulated to be related to strenuous resistance training [13], in
a latest series of reports by Cadegiani and Kater [10, 11, 14] OTS was postulated to be induced
by energy imbalance, independent of excessive training. A major outcome of these studies was
that OTS could result in “paradoxical deconditioning” [11]. Notably, OTS could be indicated by
lower salivary cortisol levels 30 minutes after waking up, which can be correlated negatively with
fatigue [9, 10, 14]. However, these studies also had certain limitations: control subjects had a
broad age range, and the analyzed parameters were not adjusted for the age difference in the
statistical analyses. Furthermore, in several of the correlation analyses a very heterogeneous
subject group was utilized, consisting of both overtrained athletes and healthy control persons
[10]. Nonetheless, a recent systematic review of 22 studies on OTS revealed that no diagnostic
evidence other than unexplained decrement in physical performance was verified as a reliable
marker of OTS, particularly in resistance training [13].
Irisin is a novel myokine and adipokine that has been found to increase adipocyte browning
in subcutaneous fat, as well as promoting thermogenesis regulated by uncoupling protein 1
(UCP1) and resting energy expenditure in rodents [15, 16]. Irisin has also been reported to be
released from contracting skeletal muscle during acute exercise in a manner that is dependent on
both the intensity and duration of the exercise [17–21]. Whereas acute exercise has been shown
to increase plasma irisin levels in some studies [20, 21], no such effect has been evident in others
[22, 23]. Although analytical studies have confirmed the existence of irisin in humans, as well as
its presence in circulation and its ability to be regulated by exercise [20, 24], the acute and
chronic effects of exercise-related irisin expression on skeletal muscle metabolism are not known
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in detail, as has been reviewed by Fatouros [25]. Huh et al. [26] demonstrated that irisin directly
stimulated MAPK (mitogen-activated protein kinase) in human myotubes in vitro. As the
MAPK pathway has a key role in energy substrate regulation in skeletal muscle during exercise,
irisin may exert direct effects on skeletal muscle metabolism. A meta-analysis [27] demonstrated
that chronic exercise training tended to lower plasma irisin levels, which may be the result of a
reduction in the body fat content [28]. In addition, a recent study among young amenorrheic
athletes suggested that low plasma irisin levels reflected a state of chronic energy deficiency [29].
Therefore, we postulated that during OTS, a dysregulation of energy metabolism would also
affect irisin levels, which could be utilized as a marker in OTS diagnosis.
We earlier reported using the same experimental setting that oxidative stress may exert an
impact on the pathophysiology of OTS [6] and, furthermore, that a pro-inflammatory cytokine
response to acute exercise may represent a chronic maladaptation state in overtrained athletes
[3]. Notably, impairments in antioxidant defense in OTS may reflect an overall regulatory
decompensation status of the organism [7]. Although the role of irisin in redox regulation and in
the control of oxidative stress and inflammation have recently been explored in different animal
models [30–32], data from exercise models, especially those mimicking OTS are still lacking.
As far as we are aware, the associations between severe OTS or other chronic physical stress
conditions and irisin have not been investigated. We therefore compared plasma irisin levels
before and after a maximal exercise test in athletes suffering from OTS as well as their peers
without OTS. Furthermore, inflammation and oxidative stress, which are controlled by irisin,
are postulated to be predisposing factors for OTS. Therefore, in order to evaluate the link be-
tween irisin and oxidative stress/inflammation and with an effort to obtain more evidence on the
pathogenesis of OTS, we analyzed the association of irisin with oxidative stress, antioxidant
protection markers and inflammatory cytokines. We also studied how recovery from OTS would
affect plasma irisin levels during 12 months of follow-up in an effort to evaluate whether irisin
would be a useful marker for monitoring recovery from exercise as well as assisting in the early
diagnosis of OTS in elite athletes.
MATERIALS AND METHODS
Participants
Seven over-trained athletes (OA, two females and five males) and 10 healthy control athletes
(CA, five females and five males) were investigated in this study. The athletes participated in
various endurance sports and were recruited when they responded to a nationwide advertise-
ment. All athletes were competing at the Finnish national level and reported no history of
smoking. The criteria for OTS diagnosis were: (1) An unexplained decrement in physical per-
formance and fatigue despite a recovery period of at least three weeks; (2) progressively
increased training volume and intensity for up to six months prior to the onset of OTS
symptoms; (3) the continuation of training without a sufficient recovery time; and (4) no reports
of chronic or recent other illnesses explaining the symptoms, i.e., the possible illnesses and
diseases were carefully medically ruled out in University Hospital [6, 33, 34]. The criteria were
confirmed by interviewing the athletes and their coaches along with an examination of training
logbooks. An experienced physician performed extensive clinical examinations with specific
laboratory tests intended to clarify the background of the symptoms of every athlete.
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The overtraining state of the present subjects was also related to higher perceived stress and
disturbed cardiac autonomic modulation detected as attenuated cardiac parasympathetic
modulation after awakening [33], during active orthostatic test (standing up) and in response to
cognitive task (Stroop Color Word Test) and to relaxation after Stroop tasks [35]. Autonomic
dysfunction in the overtrained athletes participating in the present study was further demon-
strated by a stronger relationship between RRi and vagally mediated RRi variability during 24-h
ECG recording compared to control athletes [36]. This relationship was normalized after 6
months of recovery from OTS [36]. Notably, severely overtrained athletes displayed a lower
cognitive performance compared to the controls. Moreover, the same OT athletes participating
in our study were reported to be moderately depressed according to their scores in both the
standardized Hamilton and the Montgomery–Asberg Depression Rating Scales, although their
brain serotonin uptake levels did not display any changes compared to the control athletes [34].
Furthermore, at the time of diagnosis, at rest the overtrained athletes had higher levels of plasma
protein carbonyls, a biomarker of oxidative stress, than the controls [6].
The female athletes had regular menses except for one CA female who had athletes’
amenorrhea symptoms. One OA female had e-pills, two of five CAs had e-pills and the CA
female with amenorrhea had progesterone pills. One male athlete in OA had sleeping pills and
antidepressant from 6 to 12 months of recovery from OTS.
The participants were informed of the study protocol that had been approved by the
Research Ethics Committee of the Hospital District of Northern Savo, and they all provided a
written consent to participate in the study.
Follow-up
During the 12 months of follow-up, the OA took part in supervised low-to-moderate intensity
exercise training to ensure a full recovery and thereafter an increase in physical performance. CA
continued their normal training routine. All athletes were examined at the time of diagnosis
(baseline) and after 6 and 12 months of follow-up. The OA were also examined after one month
of follow-up, but only the basic characteristics of the participants at this time point are shown,
and the one-month plasma measurements were not included in the statistical analyses. At each
study visit, OA were examined to determine whether they still displayed signs of OTS [6, 33, 34].
The athletes were examined 2 h after a light breakfast, and were instructed to abstain from
strenuous physical activity on the day before the examinations and not to drink coffee, tea,
chocolate, or cola drinks on the examination morning or the previous evening. The athletes were
also instructed not to drink alcohol 48 h before the examinations.
Experimental testing
Cardiorespiratory fitness was assessed by a maximal exercise test supervised by a physician and
performed to volitional exhaustion using the Ergoline Ergo-metrics 900 bicycle ergometer
(Ergoline, Bitz, Germany). To define peak oxygen consumption (VO2 peak) due to the graded
type of exercise test conducted on the bicycle ergometer, pulmonary gas exchange values were
measured by the breath-by-breath method using the SensorMedix Vmax 29 analyzer (Care-
Fusion, San Diego, California, USA). The analyzer was calibrated before each test and was
verified immediately after every test. Heart rate was recorded using the Marquette Hellige
electrocardiography (ECG) recorder (GE Medical Systems, Freiburg, Germany), and the rating
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of perceived exertion was evaluated with the Borg scale. Standard physiological criteria were
used to determine maximal effort (American College of Sports Medicine, 2001). The clinical
examination performed by a physician also excluded the possibility that cardiac, lung and
muscle pathologies lay behind the underperformance. Body fat percentage and lean body mass
were measured by bioelectrical impedance analysis using the InBody 3.0 body composition
analyzer (Biospace, Seoul, South Korea).
Biochemical Indices
Blood samples taken at rest and immediately after exercise were collected from an antecubital
vein into lithium-heparin tubes and centrifuged immediately after collection at 1,200 g and 4 8C
for 15 min to separate the plasma. Plasma samples were stored in multiple portions at 80 8C
until analysis. Samples were thawed only once for the measurement of oxidative stress and
antioxidant markers [6]. Plasma irisin levels were measured using ELISA kits (Phoenix Phar-
maceuticals Inc, Belmont, CA, USA) according to the manufacturer’s protocol. According to our
analyses, the intra-assay variation was 3.90% and the inter-assay variation was 7.57%. Because of
the sigmoidal character of the concentration changes in response to different standard con-
centrations and different sample dilutions, special caution was taken to determine optimal
sample dilution in order for the absorbance values to be in the region of maximal linearity. In
our measurements we achieved readings that corresponded to the linear part of the standard
curve. IL-6, TNF-a, IL-10, IL-1b, leptin, IGF-1, oxygen radical absorbance capacity (ORAC),
total malondialdehyde (MDA) and nitrotyrosine levels were measured as previously described
[15, 37].
Statistical analysis
The statistical analyses were performed using the IBM SPSS Statistics software, Version 19.0
(IBM Corporation, Armonk, New York, USA). The normality of the residuals was inspected
visually from histograms. Homogeneity of variance was inspected by plotting residuals against
predicted values. Non-parametric tests were used for analyzing the data with non-normal
distribution. Pearson’s coefficients for correlation were calculated for normally distributed
variables. The groups were compared with the linear mixed-effects models using group, time,
exercise, and sex as fixed factors. Body fat percentage was also included in the model. As-
sociation of irisin levels with IL-6, TNF-a, IL-10, IL-1b, leptin, IGF-1, MDA, ORAC and
nitrotyrosine was assessed by Pearson’s correlation test for normally distributed variables and by
Spearman’s correlation test for skewed variables. The results are presented as mean ± standard
deviation (SD). Differences with P-values < 0.05 were considered statistically significant.
Statistical power analysis was performed by GLIMMPSE software [38]. Varying results from
the previous heterogenic study designs complicate the power analysis. If we were to detect
similar (approximately 1.2-fold) post-exercise increases in irisin concentration as observed in
some previous studies involving trained [21, 26] and untrained individuals [18], then we would
achieve power >80% (alpha 5 0.05). In order to achieve power >80% in detecting between-
group differences of the same magnitude, a total N of approximately 20–30 would have been
needed depending on the expected variability. In fact, our observed power was a reasonable,
although modest, 60%.
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RESULTS
Basic participant characteristics
The basic characteristics of the participants are presented in Table 1. Fat percentage was
higher in OA regardless of the gender as we have previously reported [3]. During one month
of follow-up, VO2peak decreased in OA but not in CA (Table 1). Only three OA were able to
exercise according to the programmed training schedule. The other OA performed light
physical activity 2–4 times per week to encourage their recovery. VO2peak increased in all OA
except one athlete during the follow-up, but the main effect of time remained statistically
non-significant in both groups and there were no differences between groups (Table 1). OTS
symptoms became exacerbated in one male OA. In another male OA, VO2peak increased but
his sport-specific symptoms did not resolve during the follow-up. Changes in heart rate were
statistically non-significant in both groups (Table 1). Three OA dropped out before the last
measurement, with the reason being that they were experiencing a worsening of their OTS
symptoms.
Plasma irisin levels
Initial plasma irisin levels were slightly lower in OA when compared to CA at rest (154.5 ± 28.5
vs. 171.7 ± 58.7 ng/mL, P > 0.050). Irisin concentrations at rest did not change during the
follow-up in either group (Fig. 1). The increase in irisin in response to acute exercise was higher
in OA than in CA at the 6 months’ follow-up (19.0 ± 69.3 vs. 8.1 ± 46.4 ng/mL, P > 0.050).
There was no statistically significant effect of time on the irisin level during the follow-up or in
the irisin response to acute exercise in CA or OA. Neither irisin levels at rest nor the irisin
response to exercise was statistically significantly correlated with OTS, recovery from OTS, or
any change in aerobic performance. Fat percentage was not associated with either irisin levels at
rest or in the irisin responses to acute exercise. Interestingly, lean body mass correlated nega-
tively with the irisin concentration in OA (r 5 0.749; P < 0.001) whereas no correlation was
detected in CA.
Table 1. Basic characteristics (mean ± standard deviation) of overtrained athletes (OAs) and control














CA 171.1 ± 6.7 64.9 ± 10.3 15.6 ± 7.2 3.8 ± 0.9 192 ± 6
6 64.4 ± 6.1 16.9 ± 8.6 4.0 ± 0.8 192 ± 8
12 64.5 ± 6.1 15.6 ± 7.9 3.9 ± 0.8 190 ± 4
OA 0 176.7 ± 9.0 71.6 ± 10.3 17.2 ± 7.9 3.8 ± 0.9 190 ± 10
1 – – 3.6 ± 0.9p 179.7 ± 13
6 74.8 ± 7.5 15.9 ± 4.2 4.2 ± 1.0 183 ± 14
0 75.0 ± 5.3 19.6 ± 13.0 4.2 ± 1.0 183 ± 12
Values are means ± SD. pDifference in VO2peak during the first month compared to the time of diagnosis in
OA (Wilcoxon signed-rank test pP 5 0.028).
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Association of irisin with oxidative stress, antioxidant markers, and inflammatory
cytokines
At baseline we observed a statistically significant positive correlation between the irisin level at
rest and the change in an oxidative stress marker, MDA, in the athletes’ response to the maximal
exercise test in OA but not in CA (Fig. 2a). In addition, a strong negative correlation of irisin at
Fig. 1. Plasma irisin levels (mean ± standard deviation) before (PRE) and after (POST) exercise test at
baseline and during the follow-up in control (CA) and overtrained athletes (OA)
Fig. 2. (a) and (b) Plasma irisin levels at baseline in control and overtrained athletes (OA) before exercise
correlated positively with the change in malondialdehyde (MDA) concentration after exercise (PRE-POST)
(r 5 0.878, P 5 0.010) and negatively with the change in oxygen radical absorbance capacity (ORAC)
(r 5 0.955, P 5 0.003)
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rest with the change in an antioxidant protection marker, ORAC, during the maximal exercise
test was also detected in OA but not in CA (Fig. 2b). Furthermore, at the time of the diagnosis,
the plasma level of irisin at rest correlated positively with the TNF-a response to the maximal
exercise test in OA (r 5 0.793, P 5 0.033). When considering all subjects in the analysis at the 6
months’ follow-up, the irisin level at rest correlated positively with the amount of nitrotyrosine
both at rest (r 5 0.655, P 5 0.006) and after maximal exercise test (r 5 0.668, P 5 0.005).
DISCUSSION
The main finding of this study was that OTS did not correlate with plasma irisin levels among
athletes. In addition, decreased training volume and intensity did not influence the plasma
concentration of irisin at rest or the irisin response to a single bout of exercise in athletes
suffering from OTS, although there was a tendency towards lower irisin levels at the time of
diagnosis and progressively decreasing irisin levels in response to acute exercise in OA during
the follow-up. On the other hand, at baseline, irisin concentrations at rest correlated positively
with changes in oxidative stress and negatively with changes in antioxidant capacity during
acute exercise. This is the first study to demonstrate the association of irisin, which is a novel
myokine, with acute exercise-induced alterations in oxidative stress and antioxidant protection
in humans.
As far as we are aware, plasma irisin levels have not been examined in overload training or in
other chronic physical stress conditions. Thus, little is known about the effects of chronic
overload training, OTS and impaired recovery from OTS on plasma irisin levels. Exercise
intervention studies showed little effect on irisin [20, 22, 23, 39]. However, changes in body
composition and nutritional status in response to exercise interventions may affect plasma irisin
levels. In fact, whole body energy status and body muscle mass may be more important irisin
regulators than exercise per se [39–41], although conflicting information also exists [42, 43]. As
energy insufficiency may be one factor in the multi-factorial pathogenesis of OTS, this may hint
that irisin, much like leptin, may be a potential marker for the development of chronic per-
formance impairment. In situations where there is a lack of energy intake, plasma irisin levels
may decrease and thus reflect the need to conserve energy reserves [29]. On the other hand, the
weight loss in response to exercise training may also lead to increased plasma irisin levels. In the
present study, we demonstrated a negative correlation of irisin with lean body mass in OA but
not in CA, whereas fat percentage was not associated with either irisin levels at rest or irisin
responses to acute exercise. Therefore, we cannot conclude that irisin levels are affected directly
by a relative increase in muscle mass [37]. Anastakilis et al. [17] detected that lean body mass
was positively correlated with irisin in both males and females and that irisin levels were higher
in females as compared to males. Despite a similar trend, we did not observe statistically sig-
nificant differences as males were compared to females. Most notably, in the present study
overtrained athletes presented higher body fat percentage than control athletes, and recently
Cadegiani and Kater have found similar results in overtrained male athletes [9]. Nevertheless, in
our study for the comparison of plasma irisin levels in both groups, linear mixed-effects models
were used, where sex and body fat percentage were set as covariates to normalize the effects of
these variables on irisin levels. There is a need for further studies to reveal how energy meta-
bolism and its markers are associated with overtraining.
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To date, the acute effects of irisin have not been extensively examined. Irisin may act as a
MAPK-activator [26], thus stimulating the same metabolic pathways as IL-6 [44]. The irisin
response to acute exercise and exercise training may be attributed to energy depletion and the
ability of an individual to restore his/her muscle ATP content. While serum irisin levels can be
induced by low ATP levels, the levels return to normal in response to the restoration of muscle
ATP content [40]. The current findings are inconsistent, and the relevance of irisin’s effect on
skeletal muscle metabolism in acute exercise needs further clarification. It seems, though, that
short-term intensive acute exercise is capable of elevating serum irisin concentrations [20, 21,
45]. Since we observed only marginal changes in irisin during acute exercise in both groups and
slightly higher plasma irisin levels after exercise in OA than in CA, one may speculate whether a
short-term progressive cycle ergometer test is sufficient to elevate plasma irisin levels in athletes,
who are fit and well trained. This proposal is supported by Huh et al. [4] who demonstrated that
serum irisin levels were increased in untrained but did not change in trained individuals in
response to an acute sprint exercise.
One reason for the discrepancy in the literature between the studies on the role of exercise in
circulating irisin levels and the physiological effects of irisin in humans may be methodological,
i.e., what are the significance of irisin in the systemic circulation and the nature of its detection
by immunoassays [20]. To resolve this latter question, an analytical study demonstrated the
validity of the immunoassay kit, in which the antibody used showed 100% cross-reactivity with a
soluble irisin precursor FNDC5 (fibronectin type III domain-containing protein 5) [20].
Moreover, the architecture of human irisin was identified and plasma irisin levels were precisely
quantified in a previous study that utilized targeted mass spectrometry with control peptides
that were enriched with stable isotopes [24].
The diagnosis of OTS is challenging because of the limited availability of biomarkers for
this syndrome and the difficulty in their interpretation. In this study, we considered the need
of elucidation of different mechanisms related to the pathogenesis of OTS and compared the
results with those of our previous publication on OTS in the same subjects where we
detected a pro-inflammatory cytokine response to acute exercise in OA as evidenced by an
increase in the pro-inflammatory IL-1b concentration only in OA, whereas the levels of the
anti-inflammatory IL-10 were greater in CA [3]. A growing number of studies investigating
the association between irisin and inflammation have demonstrated an anti-inflammatory
role of irisin in several pathological conditions (for a review see Askari et al. [46]). Here, we
showed that at the baseline, irisin at rest correlated with the TNF-a response to a maximal
exercise test in OA, suggesting that irisin reacts to unbalanced cytokine metabolism, which
might be evident in OTS.
Moreover, we have earlier reported that resting oxidative stress was increased during OTS as
demonstrated by higher plasma levels of protein carbonyls in OTS than in controls and by
antioxidant protection not reacting to acute exercise-induced stress [6]. Moreover, acute exercise
increased total antioxidant capacity as measured by ORAC in controls but not in OA at baseline
and six months’ follow-up [6]. Margonis et al. [7] found that a 12-week resistance-training
period caused a performance decline, interpreted as overtraining, and a marked response in the
oxidative stress biomarkers which, in some cases, was proportional to the training load.
Impaired antioxidant protection in OTS may be a result of a stage of overall regulatory
decompensation in an athlete suffering from OTS. In the present study, we found that plasma
irisin levels at rest correlated positively with changes in lipid peroxidation and negatively with
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changes in ORAC in the response to a single bout of exercise at the time of the diagnosis of OTS.
Furthermore, after six months of follow-up plasma irisin levels at rest correlated positively
with plasma nitrotyrosine concentrations at rest and after acute exercise when including all
the subjects in the analysis. The association of irisin with oxidative stress remained unclear
for a long time until the recent mechanistic studies on the multifaceted role of irisin in the
regulation of redox homeostasis. Irisin is a peroxisome proliferator-activated receptor
gamma coactivator1-alpha- (PGC1 a)-dependent myokine, and PGC-1a contributes to the
control of mitochondrial biogenesis and the regulation of mitochondrial antioxidant en-
zymes superoxide dismutase and glutathione peroxidase [30]. Recent studies have revealed
that the antioxidant role of irisin is mediated mainly through the nuclear translocation-
mediated nuclear factor (erythroid-derived 2)-like 2 (Nrf2) protein pathways [3, 24]. Nrf2 is
generally considered as an essential transcription factor in the protection against oxidative
stress by enhancing the expression of various antioxidant genes [31, 32]. Furthermore, in-
dependent of the Nrf2 pathway, FNDC5 overexpression or irisin supplementation induced
the expression of target proteins of Nrf2, including heme-oxygenase-1 (HO-1), and
consequently it attenuated NADPH oxidase activity, a major source of reactive oxygen
species (ROSs) [32]. These results collectively provide evidence for the role of irisin in the
modulation of oxidative stress, suggesting that it may be responsive to increased oxidative
stress and lower antioxidant capacity.
In addition to the inflammatory and oxidative stress markers, several hormones have been
utilized to reveal the pathogenesis and diagnosis of OTS, including testosterone. A number of
recent studies point out a tight association between irisin and testosterone, although some
controversy exists. A previous study reported that circulating irisin was inversely associated with
serum testosterone levels in patients with metabolic syndrome, particularly in the subjects with
hypogonadism [47]. In contrast to these results, the same group recently demonstrated a positive
association of circulating irisin with serum testosterone, where a testosterone replacement
therapy considerably increased serum irisin levels [48]. Likewise, chronic exposure to irisin
resulted in increased levels of testosterone levels in male rats [49]. Since we have a group of OTS
and control athletes including members of both sexes, and we did not measure testosterone
levels in the present study, the relationship between irisin and testosterone remains out of the
scope of this report.
Our study provides novel insights into the physiological role of irisin in athletes. In addition,
we had the opportunity to evaluate how irisin might associate with OTS. There are a few
important restrictions to take into account when interpreting our results. Our study population
is small due to the strict diagnostic criteria of OTS, the rarity of true OTS and difficulties in the
recruitment of participants. Therefore, the statistical power was limited and some of the dif-
ferences between the study groups remained statistically non-significant despite the presence of
trends in the results. As all of the OA had individual recovery speeds and training programs, it is
difficult to evaluate whether or not it was the increasing training volume and intensity after
recovery that had affected plasma irisin levels. Furthermore, a more strenuous exercise test
might have been needed to evoke a statistically significant irisin response to acute exercise.
Importantly, our study is applicable only to the athletes participating in high volume endurance
training. Moreover, lack of precise data on diet, energy intake, and energy expenditure of the
participants restricts interpretation of the results.
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CONCLUSIONS
OTS or the recovery from this syndrome among athletes did not correlate either with plasma
irisin levels or its response to a single bout of exercise despite a tendency towards lower irisin
levels at the time of diagnosis and during the follow-up in OA. Furthermore, changes in the
plasma irisin concentration were not associated with the modifications of normal training
routine or altered aerobic performance. Nevertheless, our results on the association of plasma
irisin levels at rest with increased oxidative stress and the antioxidant capacity in response to
acute exercise provide novel evidence on the regulatory role of irisin in the antioxidant defense
against exercise-induced oxidative stress, one of the putative mechanisms of OTS pathogenesis.
Further research is warranted to clarify the role of irisin in the adaptation to intensive exercise
training and OTS.
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